575 (Janumet 500 mg / 50 mg)
Generic Name: metformin/sitagliptin
Pill imprint 575 has been identified as Janumet 500 mg / 50 mg.
Janumet is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Janumet 500 mg / 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- metformin/sitagliptin
- Imprint:
- 575
- Strength:
- 500 mg / 50 mg
- Color:
- Pink
- Size:
- 17.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-0575
- Inactive Ingredients:
- ferrosoferric oxide
microcrystalline cellulose
polyethylene glycol
polyvinyl alcohol
povidone k29/32
ferric oxide red
sodium lauryl sulfate
sodium stearyl fumarate
magnesium silicate
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 35356-0136 | Lake Erie Medical and Surgical Supply (repackager) |
| 54868-5973 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More about Janumet (metformin / sitagliptin)
Consumer resources
Professional resources
Other formulations
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
